Abstract
Malignant triton tumour (MTT) is a rare, highly malignant neoplasm, characterized by a mixture of cells with nerve sheath and skeletal muscle differentiation. Cytogenetic analyses of this neoplasm are rare to date and none comparative genomic hybridisation (CGH) analysis has been published. In the present study we report about the genomic imbalances of a MMT analysed by CGH, in a 39-year-old male patient without neurofibromatosis. We observed the amplifications at chromosomal location 1p, 6p, 16p, 16q, 17p, 17q, 19p, 19q, 20p, and 22q. Comparing our results with those of previous studies, we found evidence for recurrent genomic aberrations at the chromosomes 1, 16, 17, 19, and 22 suggesting the involvement of several oncogenes in the genesis of MTT.
References
Weiss SW, Goldblum JR (2007) Enzinger and weiss’s soft tissue tumors, 5th edn. Mosby, Missouri
Ducatman BS, Scheithauer BW (1984) Malignant peripheral nerve sheath tumors with divergent differentiation. Cancer 54(6):1049–1057
Brooks JS, Freeman M, Enterline HT (1985) Malignant “triton” tumors: natural history and immunohistochemistry of nine cases with literature review. Cancer 55(11):2543–2549
Travis JA, Sandberg AA, Neff JR, Bridge JA (1994) Cytogenetic findings in malignant triton tumor. Genes Chromosomes Cancer 9:1–7
McComb EN, McComb RD, DeBoner JM, Neff JR, Bridge JA (1996) Cytogenetic analysis of a malignant triton tumor and a malignant peripheral nerve sheath tumor and a review of literature. Cancer Genet Cytogenet 91:8–12
Henning Y, Löschke S, Katenkamp D, Bartnitzke S, Bullerdiek J (2000) A malignant triton tumor with an unbalanced translocation (1;13) (q10;q10) and an isochromosome (8)(q10) as the sole karyotypic abnormalities. Cancer Genet Cytogenet 118:80–82
Haddadin MH, Hawkins AL, Long P, Morsberger LA, Depew D, Epstein JI, Griffin CA (2003) Cytogenetic study of malignant triton tumor: a case report. Cancer Genet Cytogenet 144:100–105
Velagaleti GV, Miettinen M, Gatalica Z (2004) Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation (malignant triton tumor) with balanced t(7;9) (q11.2;p24) and unbalanced translocation der (16)t(1;16) (q23;q13). Cancer Genet Cytogenet 149:23–27
Magrini E, Pragliola A, Fantasia D, Calabrese G, Gaiba A, Farnedi A, Collina G, Pession A (2004) Acquisition of i(8q) as an early event in malignant triton tumors. Cancer Genet Cytogenet 2:150–155
Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A (1992) Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13:718–725
du Manoir S, Schrock E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T (1995) Quantitative analysis of comparative genomic hybridization. Cytometry 19:27–41
Nikitin AY, Lennartz K, Pozharisski KM, Rajewsky MF (1991) Rat model of the human “triton” tumor: direct genetic evidence for the myogenic differentiation capacity of schwannoma cells using the mutant neu gene as a cell lineage marker. Differentiation 48:33–42
Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, Nakamura Y, Kaneko Y (1994) There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chrom Cancer 10:30–39
Speleman F, Van Camp G, Van Roy N (1996) Reassignment of MYCL1 to human chromosome 1p34.3 by fluorescence in situ hybridization. Cytogenet Cell Genet 72:189–190
McCusick VA, Antonarakis SE, Francomano CA, Hurko O, Scott AF, Smith M, Valle D (1998) Mendelian inheritance in man: a catalog of human genes and genetic disorders, 12th edn. The Johns Hopkins University Press, Baltimore
Rylova SN, Amalfitano A, Persaud-Sawin DA, Guo WX, Chang J, Jansen PJ, Proia AD, Boustany RM (2002) The CLN3 gene is a novel molecular target for cancer drug discovery. Cancer Res 62:801–808
Horwitz M, Benson KF, Li FQ, Wolff J, Leppert MF, Hobson L, Mangelsdorf M, Yu S, Hewett D, Richards RI, Raskind WH (1997) Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21–23.2. Am J Hum Genet 61:873–881
Plaat BE, Molenaar WM, Mastik MF, Hoekstra HJ, te Meerman GJ, van den Berg E (1999) Computer assisted cytogenetic analysis of 51 malignant perpheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-I-associated malignant schwannomas. Int J Cancer 83:171–178
Slagle BL, Zhou YZ, Butel JS (1991) Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res 51(1):49–54
Hall JM, Friedman L, Guenther C, Lee MK, Weber JL, Black DM, King MC (1992) Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet 50:1235–1242
Vahteristo P, Tamminen A, Karvinen P, Eerola H, Eklund C, Aaltonen LA, Blomqvist C, Aittomaki K, Nevanlinna H (2001) p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Cancer Res 61:5718–5722
Westermann F, Schwab M (2002) Genetic parameters of neuroblastomas. Cancer Lett 184(2):127–147
Liu S, Liu W, Jakubczak JL, Erexson GL, Tindall KR, Chan R, Muller WJ, Adhya S, Garges S, Merlino G (2002) Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis. Proc Natl Acad Sci 99:3770–3775
Romashkova JA, Makarov SS (1999) NF-kappa-B is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86–90
Gill S, Stratton MR, Patterson H, Spurr NK, Fisher C, Gusterson BA, Cooper CS (1991) Detection of transforming genes by transfection of DNA from primary soft-tissue tumours. Oncogene 6(9):1651–1656
Lin L, Prescott MS, Zhu Z, Singh P, Chun SY, Kuick RD, Hanash SM, Orringer MB, Glover TW, Beer DG (2000) Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res 60(24):7021–7027
Martinerie C, Cannizzaro LA, Croce CM, Huebner K, Katzav S, Barbacid M (1990) The human VAV proto-oncogene maps to chromosome region 19p12–19p13.2. Hum Genet 86:65–68
Mathas S, Hinz M, Anagnostopoulos I, Krappmann D, Lietz A, Jundt F, Bommert K, Mechta-Grigoriou F, Stein H, Dorken B, Scheidereit C (2002) Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa-B. EMBO J 21:4104–4113
Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Benedetti Panici P, Mancuso S, Neri G, Testa JR (1995) Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64(4):280–285
Acknowledgments
This study was supported by a grant of the foundation Tumor Research Head, and Neck, Wiesbaden, Germany.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koutsimpelas, D., Brieger, J., Heinrich, U. et al. Cytogenetic analysis of a malignant triton tumour by comparative genomic hybridization (CGH) and review of the literature. Eur Arch Otorhinolaryngol 268, 1391–1396 (2011). https://doi.org/10.1007/s00405-011-1658-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-011-1658-z